Three of the 12 mice implanted with the DAR PDX (all in the delayed treatment group) suffered local recurrences, and these were the only 3 mice to develop metastases (both lymphatic, to ipsilateral axillary nodes, and hematogenous to the kidney, ovary, and peritoneum)

Three of the 12 mice implanted with the DAR PDX (all in the delayed treatment group) suffered local recurrences, and these were the only 3 mice to develop metastases (both lymphatic, to ipsilateral axillary nodes, and hematogenous to the kidney, ovary, and peritoneum). correlated with increased nuclear beta-catenin staining and increased expression of the bone differentiation marker osteopontin. These findings suggest that Wnt signaling is anti-tumorigenic in osteosarcoma, and support the targeting of DKK-1 as an anti-metastatic strategy for patients with osteosarcoma. Keywords:sarcoma, metastasis, Wnt signaling, DKK-1, mouse model == INTRODUCTION == Osteosarcoma is the most common bone tumor of adolescents and young adults [1,2]. Surgery alone cures only a small minority of patients who present with localized disease [3,4]. The introduction of systemic chemotherapy resulted in rates of long term survival approaching 75% in patients with localized osteosarcoma, but has had a minimal impact on the survival of patients who present with metastatic disease [5,6]. Numerous clinical trials with increasingly intensive chemotherapy regimens have failed to improve survival rates for this population, which has led to a focus on understanding the biology of osteosarcoma metastasis in the hopes that this will lead to the development of new approaches targeting metastasis-specific cellular pathways [4]. The Wnt signaling pathway has been the focus of intense investigation in osteosarcoma because of its role in normal bone development. The Wnt family is composed of 19 secreted glycoproteins that are required for, among other things, skeletal development and homeostasis [7]. Wnt ligands bind to transmembrane receptors, including the 10 members of the Frizzled family of G protein coupled receptors (which mediate -catenin-dependent, or canonical signaling) and the receptor tyrosine kinases ROR1 and ROR2 and the receptor tyrosine kinase-like receptor RYK (which mediate so-called noncanonical signaling) [8]. The extraordinary complexity of the Wnt signaling system is further complicated by the existence of secreted Wnt antagonists such as the secreted frizzled-related proteins and Wnt inhibitory factor 1 (WIF1), which bind Wnt proteins, and sclerostin and the dickkopf family of proteins, which interact with Wnt receptors [7]. Canonical, -catenin-dependent Wnt signaling enhances osteoblastogenesis and bone formation and decreases osteoclastogenesis and bone resportion [7]. Interestingly, activation of noncanonical signaling by Wnt5a binding to ROR2 enhances osteoclastogenesis and bone resorption [9], while Wnt5a signaling through the G-protein-linked activation of Protein Kinase C induces osteoblastogenic differentiation of murine mesenchymal stem cells [10]. The role of Wnt signaling in the pathogenesis of osteosarcoma is unclear. Although Wnt signaling has been implicated as a driver of osteoblast differentiation, other work has suggested that Wnt signaling may also drive proliferation of osteosarcoma cells. For example, Mitoquinone mesylate Kansara and colleagues reported that WIF1 is epigenetically silenced in human osteosarcoma cell lines [11].In vitro, WIF1 suppresses -catenin expression in osteosarcoma cell lines and induces differentiation of primary human osteoblasts, and in primary human osteosarcoma samples, silencing of WIF1 is associated with increased proliferation, increased -catenin expression, and loss of differentiation, implying that de-repression of Wnt signaling plays a positive role in osteosarcoma pathogenesis. In similar work, Zhao et al performed microarray analysis of an osteosarcoma genetically engineered mouse model, comparing localizedvsmetastatic tumors and found downregulation of NKD2, a negative Mitoquinone mesylate regulator of Wnt signaling, in metastatic tumors compared with localized tumors [12]. Overexpression of NKD2 in osteosarcoma cell line decreased proliferation, migration, and invasionin vitroand diminished tumor growth and metastasisin vivo, consistent with a model wherein Wnt signaling potentiates these aggressive behaviors in osteosarcoma. In striking contrast, there are several reports of dickkopf-1 (DKK-1), also a Wnt signaling antagonist, possibly playing a pro-tumorigenic role in osteosarcoma. The dickkopf family of proteins are secreted Mouse monoclonal to GTF2B glycoproteins that have an allosteric inhibitory effect on LRP 5/6, which the Mitoquinone mesylate Wnt/Frizzled complex requires to inactivate axin and release -catenin in the canonical Wnt pathway [13]. The group comprises five molecules; DKK-1 through DKK-4 and.